Pyoderma Gangrenosum (Pathergy Trap): Rapidly Expanding Violaceous Undermined Ulcer and Why Surgical Debridement Catastrophically Worsens Necrosis¶

Pyoderma gangrenosum (PG) is a rare, non-infectious, autoinflammatory neutrophilic dermatosis in which dysregulated innate immune signaling drives massive numbers of mature, sterile polymorphonuclear neutrophils into the dermis, melting collagen and subcutaneous tissue within hours to days. Despite its misleading historical name coined in 1930, pyoderma gangrenosum is neither a bacterial infection ("pyoderma") nor true ischemic vascular gangrene. Instead, it typically begins as a tender inflammatory papule, sterile pustule, or hemorrhagic vesiculopustule, often triggered at the exact site of a minor skin injury, insect bite, venipuncture, or surgical incision, a hallmark phenomenon known as cutaneous pathergy (present in 30 to 50 percent of patients). Within 24 to 72 hours, the sterile pustule breaks down centrally and expands centrifugally at a terrifying speed (1 to 2 centimeters per day) into an excruciatingly painful, purulent, necrotic crater ringed by a pathognomonic boggy, gunmetal-gray to deep violaceous (purple-blue), undermined, overhanging border surrounded by a bright erythematous halo. Between 50 and 70 percent of patients with pyoderma gangrenosum have an underlying systemic disease, most commonly Inflammatory Bowel Disease (Ulcerative Colitis or Crohn Disease), Rheumatoid Arthritis or Seronegative Spondyloarthritis, Monoclonal Gammopathy (specifically IgA paraproteinemia), or Hematologic Malignancy (Acute Myeloid Leukemia or Myelodysplastic Syndrome). Because a rapidly expanding, purulent ulcer accompanied by fever, severe pain, and a white blood cell count of 20,000 to 40,000 cells/mcL closely mimics necrotizing fasciitis (flesh-eating bacterial infection) or a postoperative wound abscess, surgeons who do not recognize pyoderma gangrenosum frequently rush the patient to the operating room for wide radical surgical debridement. In pyoderma gangrenosum, every stroke of the surgeon's scalpel triggers an explosive pathergic neutrophil storm along the freshly cut skin margin, causing the ulcer to double or triple in size overnight, exposing tendons and bone, or leading to unnecessary limb amputation. If a patient develops a rapidly expanding ulcer with a purple undermined border after minor trauma or surgery, call your local ايمرجنسي نمبر or seek urgent hospital dermatology evaluation immediately. Also review our sibling guides on calciphylaxis, violaceous retiform plaques, and sodium thiosulfate, erysipelas vs necrotizing fasciitis vs stasis dermatitis triage، ۽ black widow latrodectism vs brown recluse loxoscelism necrotic ulcer triage.

Your immediate emergency priorities are to place an immediate "DO NOT SURGICALLY DEBRIDE" warning on the patient's chart and wound dressing, differentiate pyoderma gangrenosum from true necrotizing soft-tissue infection using bedside clinical examination, Gram stain, tissue cultures, and the validated PARACELSUS or Delphi Diagnostic Criteria, perform a cautious elliptical or punch skin biopsy of the active violaceous border (only if needed to exclude infection, vasculitis, or malignancy, and ideally while initiating systemic immunosuppression to blunt biopsy pathergy), and start rapid-acting systemic anti-neutrophil immunosuppression, specifically high-dose systemic Corticosteroids (oral Prednisone 1 to 2 mg/kg/day or pulse IV Methylprednisolone 500 to 1,000 mg/day for 3 days), oral Cyclosporine (4 to 5 mg/kg/day), or intravenous Infliximab (5 mg/kg, the gold standard for Crohn/Ulcerative Colitis-associated and peristomal PG).

ھاڻي ھي ڪر¶

1. Seek Urgent Hospital Emergency and Dermatology Evaluation if a skin pustule, surgical incision, or minor bruise rapidly ulcerates into an excruciatingly painful crater with a purple-blue, boggy, overhanging border. Dial 911 in the United States and Canada, 999 in the United Kingdom, 112 across the European Union, 000 in Australia, or consult our global directory of ايمرجنسي نمبر.
2. STOP Any Planned Sharp Surgical Debridement or Wide Excision Immediately (The Pathergy Trap): If a patient has known or strongly suspected pyoderma gangrenosum (including Postoperative Pyoderma Gangrenosum [PPG] appearing 4 to 14 days after breast reduction/reconstruction, cesarean section, cardiothoracic surgery, or abdominal stoma creation), sharp surgical debridement with a scalpel or curette is strictly contraindicated. Surgical cutting recruits massive waves of IL-1beta-, IL-8-, and TNF-alpha-driven neutrophils to the newly incised dermis, causing catastrophic centrifugal ulceration across the entire chest, abdomen, or limb within 24 hours.
3. Rule Out True Necrotizing Fasciitis, Ecthyma Gangrenosum, and Deep Fungal Infection Without Triggering Unnecessary Radical Excision:
4. Why Surgeons Get Tricked: Pyoderma gangrenosum causes a creamy yellow-white sterile purulent exudate (composed of millions of dead neutrophils), high fever, and leukocytosis up to 35,000/mcL.
5. How to Tell Them Apart at the Bedside: Unlike necrotizing fasciitis (which spreads deep along the subcutaneous muscle fascia ahead of visible skin breakdown, produces subcutaneous gas/crepitus, foul "dishwater" fluid, and systemic septic shock with hypotension and lactic acidosis), pyoderma gangrenosum is a primary dermal ulceration with a sharply demarcated, boggy, gunmetal-violaceous undermined overhang, zero subcutaneous gas, zero foul anaerobic odor, palpable peripheral pulses, and negative Gram stains and blood cultures.
6. Postoperative PG Clue: Postoperative bacterial necrotizing wound infections typically strike within 24 to 72 hours of surgery (Group A Streptococcus or Clostridium) or present as a fluctuant stitch abscess, whereas Postoperative Pyoderma Gangrenosum (PPG) classically erupts 4 to 14 days post-op as multiple small sterile pustules along the suture line that coalesce and dehisce the entire incision while sparing the pale nippled areola in breast surgery and failing to improve on broad-spectrum IV antibiotics.
7. Apply Validated Diagnostic Frameworks (The Delphi International Consensus Criteria and the PARACELSUS Score) and Obtain a Targeted Border Biopsy:
8. Under the 2018 Delphi International Consensus, diagnosis requires 1 Major Criterion (biopsy of the ulcer edge demonstrating a dense sterile neutrophilic dermal infiltrate) plus at least 4 of 8 Minor Criteria (exclusion of infection on histology/culture; pathergy; history of IBD or inflammatory arthritis; papule/pustule ulcerating within 4 days; peripheral erythema, undermining border, and tenderness; multiple ulcerations with at least one on the anterior lower leg; cribriform or "crushed tissue paper" wrinkled scars at healed sites; and decrease in ulcer size within 1 month of starting immunosuppressive medication).
9. Under the PARACELSUS Score (where a score of >= 10 points indicates a > 90% probability of PG), major points are awarded for Progressing disease (3 pts), Assessment of relevant differential diagnoses (3 pts), and Reddish-violaceous wound border (3 pts), plus Amelioration by immunosuppressants (2 pts), Characteristic bizarre ulcer shape (2 pts), Extreme pain > 4/10 on VAS (2 pts), and Localized pathergy phenomenon (2 pts).
10. Start High-Dose Systemic Corticosteroids or Cyclosporine Immediately to Halt the Neutrophil Storm:
11. First-Line Systemic Rescue (STOP GAP Trial Evidence): Administer Oral Prednisolone/Prednisone at 0.75 to 1.5 mg/kg/day (up to 60 to 100 mg/day), or for fulminant, rapidly expanding multilocular or postoperative PG, administer Pulse Intravenous Methylprednisolone (500 to 1,000 mg IV once daily for 3 to 5 consecutive days), which typically arrests centrifugal border expansion and reduces agonizing pain within 48 to 72 hours.
12. Alternative First-Line Rescue (Oral Cyclosporine): The landmark UK STOP GAP randomized controlled trial proved that Oral Cyclosporine at 4 to 5 mg/kg/day (divided twice daily) has identical ulcer healing efficacy and speed to oral prednisolone, making Cyclosporine the preferred first-line agent in patients with brittle diabetes, severe osteoporosis, obesity, or steroid psychosis (avoid Cyclosporine in renal insufficiency or uncontrolled hypertension).
13. Initiate Biologic TNF-Alpha Blockade (IV Infliximab 5 mg/kg) for Inflammatory Bowel Disease-Associated, Peristomal, or Steroid-Refractory Pyoderma Gangrenosum: Intravenous Infliximab (5 mg/kg at Weeks 0, 2, and 6, then every 8 weeks) is the only biologic therapy supported by a randomized placebo-controlled trial for pyoderma gangrenosum, achieving rapid clinical response in 69 percent of patients within 2 weeks and serving as the undisputed treatment of choice when PG coexists with active Crohn disease, Ulcerative Colitis, or peristomal ulceration.
14. Practice Strictly Atraumatic, Moisture-Balanced Local Wound Care and Gentle Compression: Never apply dry gauze that sticks to the ulcer bed and rips viable dermis upon removal (triggering pathergy). Protect the surrounding intact skin with a zinc oxide or cyanoacrylate barrier film, apply super-potent topical clobetasol propionate 0.05% ointment or topical tacrolimus 0.1% ointment directly onto the inflamed violaceous overhanging border, dress the central crater with non-adherent silicone mesh, hydrogel, or hydrofiber/alginate dressings, and apply gentle multi-layer compression bandaging once acute border pain is controlled by systemic steroids.

Decision tree: suspected Pyoderma Gangrenosum vs Necrotizing Fasciitis vs Venous/Arterial Ulcer vs Martorell Ulcer¶

flowchart TD
    A["Patient Presents with Rapidly Expanding, Excruciatingly Painful Cutaneous Ulcer (1 to 2 cm/day) + Purulent Yellow Base + Boggy Violaceous/Gunmetal-Gray Undermined Overhanging Border (Often After Minor Trauma, Venipuncture, or Recent Surgery)"] --> B{"Step 1: Immediate Rule-Out of True Necrotizing Soft-Tissue Infection (Necrotizing Fasciitis): Is There Subcutaneous Gas/Crepitus, Foul Anaerobic Odor, Fascial Tracking Beyond Skin Margins, or Septic Shock?"}
    B -->|YES: True Bacterial Necrotizing Fasciitis / Wet Gangrene| C["Emergency Operating Room Surgical Exploration & Debridement + IV Vancomycin + Piperacillin-Tazobactam/Meropenem + Clindamycin"]
    B -->|NO: Primary Dermal Ulceration with Violaceous Undermined Overhang + Negative Gram Stain + Palpable Pulses| D["Step 2: Apply PARACELSUS Score (>= 10 Points) & Screen for Systemic Associations: IBD (Ulcerative Colitis / Crohn), Rheumatoid Arthritis, IgA Gammopathy / AML / MDS, or Levamisole-Adulterated Cocaine Use"]
    D --> E["MANDATORY SAFETY ORDER: Place 'STRICT PATHERGY PRECAUTIONS - NO SHARP SURGICAL DEBRIDEMENT, NO DRY ADHERENT GAUZE' Sign at Bedside"]
    E --> F{"Step 3: Perform Targeted Edge Biopsy (Include Violaceous Border + Subcutaneous Fat) for H&E Histopathology + Bacterial, Fungal & Mycobacterial Tissue Cultures"}
    F --> G{"Assess Disease Severity, Extent & Underlying Systemic Comorbidities"}
    G -->|Severe, Rapidly Expanding, Multilocular, or Postoperative PG| H["FIRST-LINE SYSTEMIC RESCUE: 1. Oral Prednisone (1 to 1.5 mg/kg/day) OR Pulse IV Methylprednisolone (500 to 1,000 mg/day x 3-5 days); OR 2. Oral Cyclosporine (4 to 5 mg/kg/day - STOP GAP Trial Equivalent)"]
    G -->|Coexisting Inflammatory Bowel Disease (Crohn / UC), Peristomal PG, or Steroid-Refractory Disease| I["BIOLOGIC RESCUE: Intravenous Infliximab (5 mg/kg at Weeks 0, 2, 6) or Adalimumab + Systemic Corticosteroid Bridge"]
    G -->|Underlying Hematologic Malignancy (AML / MDS / IgA Myeloma) or Severe Sepsis Contraindicating Steroids| J["High-Dose Intravenous Immunoglobulin (IVIG 2 g/kg over 2-5 days) or Targeted IL-1 Antagonist (Anakinra / Canakinumab) + Treat Underlying Leukemia/Myeloma"]
    G -->|Small (< 3 cm), Early, Localized, or Mild Peristomal Ulcer| K["Super-Potent Topical Clobetasol 0.05% Ointment or Topical Tacrolimus 0.1% Applied to Violaceous Border + Cautious Intralesional Triamcinolone (40 mg/mL) + Non-Adherent Silicone Dressings"]

Pathophysiology: the sterile neutrophil storm, cutaneous pathergy, and the five clinical variants of Pyoderma Gangrenosum¶

Pyoderma gangrenosum sits at the severe ulcerative end of the neutrophilic dermatoses spectrum (alongside Sweet syndrome, subcorneal pustular dermatosis, hidradenitis suppurativa, and erythema elevatum diutinum).

HOW MINOR TRAUMA TRIGGERS EXPLOSIVE PATHERGIC ULCERATION IN PG
=======================================================================
[Minor Cutaneous Trauma: Needle Stick, Bug Bite, Scalpel Incision]
                               |
                               v
[Keratinocyte Damage Releases DAMPs (Damage-Associated Molecular
 Patterns: ATP, HMGB1, S100 Proteins, LL-37 Cathelicidin)]
                               |
                               v
[Hyper-Reactive NLRP3 Inflammasome Activation in Dermal Macrophages]
   * Massive local surge of Interleukin-1 beta (IL-1beta), IL-1alpha,
     Tumor Necrosis Factor-alpha (TNF-alpha), IL-8 (CXCL8), IL-17,
     and Granulocyte Colony-Stimulating Factor (G-CSF).
                               |
                               v
[STERILE NEUTROPHIL AVALANCHE INTO THE DERMIS]
   * Millions of mature neutrophils flood the dermis and release
     Matrix Metalloproteinases (MMP-9, MMP-2), Neutrophil Elastase,
     Myeloperoxidase, and Neutrophil Extracellular Traps (NETs).
                               |
                               v
[LIQUEFACTIVE DERMAL COLLAGEN MELTDOWN ("Undermining")]
   * Because neutrophils dissolve the deep reticular dermis faster
     than the overlying epidermis dies, the dermal floor caves in
     beneath the skin edge -> Creates the classic BOGGY, VIOLACEOUS,
     OVERHANGING ("UNDERMINED") BORDER + Cribriform "Tissue Paper" Scar.
=======================================================================

Pyoderma Gangrenosum جا پنج مختلف ڪلينڪ ورجن¶

1. Classic Ulcerative Pyoderma Gangrenosum (85% of Cases): Most frequently erupts on the anterior pretibial lower legs (70%), trunk, or abdomen. Begins as a tender deep red nodule or sterile pustule surrounded by an erythematous halo that rapidly necroses centrally into a deep ulcer with a purulent-appearing sterile base and a boggy, bluish-purple (violaceous), undermined overhanging border. When it heals under immunosuppression, re-epithelialization grows out from spared hair follicles in bridges, leaving a pathognomonic cribriform ("sieve-like" or "crushed cigarette/tissue paper") atrophic scar.
2. Bullous (Atypical) Pyoderma Gangrenosum (Hematologic Malignancy Red Flag): Presents with acute, painful, superficial concentric hemorrhagic bullae (blood-filled blisters) with a blue-gray inflammatory halo, predominantly on the face, dorsal hands, and upper extremities rather than the legs. Critical Oncology Pearl: Over 70 percent of patients with Bullous Pyoderma Gangrenosum have an underlying hematologic malignancy, specifically Acute Myeloid Leukemia (AML), Myelodysplastic Syndrome (MDS), Myeloproliferative Neoplasms, or IgA Multiple Myeloma, and it frequently overlaps clinically and histologically with bullous Sweet syndrome.
3. Pustular Pyoderma Gangrenosum (Acute IBD Flare Marker): Presents as crops of painful, discrete 2 to 5 millimeter sterile pustules surrounded by an erythematous halo on the extensor limbs and upper trunk that do not all progress to deep craters; occurs almost exclusively during acute, severe flares of Ulcerative Colitis or Crohn Disease and resolves when the bowel flare is treated with corticosteroids or infliximab.
4. ** Vegetative (Superficial Granulomatous) Pyoderma Gangrenosum:** ھڪ سست، گھٽ دردناڪ، ويروڪوس (وارٽ جھڙو)، سُپرفيشل السرٽيو پلاڪ جنھن ۾ سائينس جي پٿرن سان گڏ جارحاڻي وائليسيس انڊرمينڊ بارڊر جو فقدان ھوندو آھي، عام طور تي ٿڙ تي ھوندو ھوندو آھي * مريض جي ھيٺان ھوندو ھوندو آھي ۽ بيماريءَ کان ٻاھر ھوندو آھي. dapsone، يا minocycline.
5. Peristomal Pyoderma Gangrenosum (PPG): Occurs immediately adjacent to an abdominal ileostomy or colostomy stoma in patients with Inflammatory Bowel Disease (accounting for 15% of all PG cases), triggered by chronic mechanical pathergy from Tight Stoma Appliance Wafers, adhesive stripping, or leaking digestive enzymes. Because the painful deep ulcer prevents the ostomy bag wafer from sealing against the skin, stool leaks continuously onto the raw crater, creating a vicious cycle of pain and appliance failure.

خود بخود جينياتي سنڊرومس جيڪي Pyoderma Gangrenosum (PAPA، PASH، ۽ PAPASH)¶

In younger patients presenting with severe, recurrent pyoderma gangrenosum accompanied by destructive acne or hidradenitis suppurativa, clinicians screen for monogenic autoinflammatory inflammasomopathies driven by mutations in the PSTPIP1 (Proline-Serine-Threonine Phosphatase Interacting Protein 1) or NCSTN genes that hyperactivate IL-1beta: - PAPA Syndrome: Pyogenic sterile Arthritis + Pyoderma gangrenosum + severe cystic Acne. - PASH Syndrome: Pyoderma gangrenosum + Acne + Suppurative Hidradenitis (hidradenitis suppurativa). - PAPASH / PASS Syndromes: Adding Psoriatic arthritis or Ankylosing Spondylitis to the triad. These syndromes respond dramatically to targeted IL-1 blockade (Anakinra or Canakinumab) or TNF-alpha inhibitors (Infliximab / Adalimumab).

Side-by-side differential diagnosis: Pyoderma Gangrenosum vs Necrotizing Fasciitis vs Martorell Hypertensive Ischemic Ulcer vs Brown Recluse Spider Bite vs Levamisole Vasculopathy¶

PARACELSUS تشخيصي اسڪور ۽ لازمي ليبارٽري ورڪ اپ مشتبہ پائوڊرما گنگرنوسوم لاءِ¶

1. پلنگ تي PARACELSUS اسڪور کي ڪيئن ڳڻيو¶

Jockenhovel ۽ ساٿين پاران شايع ٿيل هڪ اعلي-حساسيت جي تشخيصي اوزار جي طور تي پائوڊرما گينگرنوسوم کي وينس، شريانين، ۽ انفڪشن جي نموني کان ڌار ڪرڻ لاء، هڪ ** 10 پوائنٽن جو مجموعي نمبر يا ان کان وڌيڪ Pyoderma Gangrenosum جي وڏي امڪان جي تصديق ڪري ٿو**: - ** مکيه معيار (3 پوائنٽس هر هڪ):** 1. Pروگرسنگ بيماري (تيزي سان وڌندڙ السريشن <6 هفتن ۾ ترقي ڪري رهيو آهي). 2. A لاڳاپيل فرق جي تشخيص جي تشخيص ۽ خارج ڪرڻ (وينس / شريان جي گھٽتائي، انفيڪشن، ويسولائٽس، ڪلسيفيليڪسس). 3. R ڳاڙهي-وائلسيس (جامني-نيرو) زخم جي سرحد. - ** معمولي معيار (هر هڪ 2 پوائنٽون):** 4. Aميليوريشن (تيز بهتري) امونوسوپريسٽنٽ دوائن ذريعي. 5. C حيرت انگيز، پولي سائڪلڪ، يا سرپيگينس السر جي شڪل جنهن جي هيٺان ڪنارن سان. 6. E انتهائي درد (> بصري اينالاگ اسڪيل تي 10 مان 4، اڪثر 10 مان 8 کان 10). 7. Lآڪلائيز پيٿرجي رجحان (السر ٽراما، سرجري، يا بايوپسي جي سائيٽ تي شروع ٿيل). - اضافي معيار (1 پوائنٽ هر هڪ): 8. S هسٽوپيٿولوجي تي اڀرندڙ سوزش (گھڻ ڊرمل نيوٽروفيلڪ انفلٽريٽ). 9. U خراب ٿيل زخم مارجن. 10. S سسٽماتي بيماري سان لاڳاپيل (IBD، رموميٽائڊ گٿريس، IgA گيموپيپي، هيماتولوجڪ خرابي).

2. Pyoderma Gangrenosum سان هر نئين تشخيص ٿيل مريض ۾ لازمي سسٽماتي ڪم¶

ڇاڪاڻ ته 50 کان 70 سيڪڙو مريض هڪ بنيادي سسٽماتي بيماري جو شڪار آهن (۽ ڇاڪاڻ ته PG ٿي سگهي ٿو سڀ کان پهرين ڪلينڪ علامتي علامت Acute Myeloid Leukemia, Myelodysplastic Syndrome, IgA Multiple Myeloma, Crohn Disease, or GPA/ANCA Vasculitis)، پينل هن مڪمل ايڊمنسٽريشن کي ترتيب ڏيو: - ** Hematologic and Paraproteinemia Screen: ** مڪمل رت جي ڳڻپ (CBC) دستي پردي جي رت جي سمير سان (مائيلوبلاسٽس، ڊيسپلاسٽڪ نيوٽروفيلس، يا اوئر راڊز جي ڳولا)، سيرم پروٽين اليڪٽرروفورسس (SPEP) سان گڏ Immunofixisation، LIFumsight (Freesum Electrophoresis) زنجيرن** (خاص طور تي هڪ IgA monoclonal gammopathy جي ڳولا ۾، PG سان لاڳاپيل کلاسک پيرا پروٽين). - معدي / سوزش واري آنڊن جي بيماري اسڪرين: ** دستن جي تفصيلي تاريخ، هيماتچوزيا، وزن جي گھٽتائي، يا زباني aphthae؛ ** Fecal Calprotectin ۽ ** Ileo-colonoscopy with mucosal biopsies** جيڪڏهن ڪي GI علامتون يا اڻ واضح ٿيل لوهه جي گھٽتائي جي انميا موجود هجي. - Vasculitis, Thrombophilia, and Drug-Induced PG Screen: c-ANCA/PR3 and p-ANCA/MPO (قطع ڪرڻ لاءِ Granulomatosis with Polyangiitis [GPA] ۽ Levamisole-Adulterated cocaine vasculopathy ** جو سبب بڻجن ٿا ، PG-جهڙوڪ ٽنگ السر سان گڏ ٻه-مثبت MPO/HNE ANCA)، Antiphospholipid antibodies (lupus anticoagulant، anticardiolipin، beta-2 glycoprotein I)، Rheumatoid factor / Anti-CCP، هيپاٽائيٽس بي، هيپاٽائيٽس بي، هيپاٽائيٽس سي، هيپاٽائيٽس سي، ايڇ ويڪسولوجيز، ايڇ ويڪسولوجيز**، ۽ ڪوڪين/Levamisole**. - Deep Edge Skin Biopsy Protocol (ٻه نمونا): هڪ تنگ elliptical incisional biopsy يا 4-to-6 mm پنچ بايپسي حاصل ڪريو جيڪا active erythematous-violaceous بارڊر کي ذيلي ذيلي چربی ۾ پکڙيل هجي: موڪليو Specimen 1 in formalin, ASMET, G&E, G&E. Fite/Ziehl-Neelsen stain، ۽ موڪليو **Specimen 2 in sterile saline for aerobic, anaerobic, fungal (Blastomyces, Cryptococcus, Histoplasma, Sporothrix), and atypical mycobacterial (*M. marinum, M. ultuitum, M.**)

قدم بہ قدم اسپتال جي علاج جو پروٽوڪول: سسٽماتي اموناسپريشن، حياتيات، ۽ پرسٽومل سنڀال¶

1. فرسٽ-لائن سسٽماتي اموناسپريشن (پريڊنيسون بمقابله سائڪلوسپورين)¶

• سسٽميڪ ڪورٽيڪوسٽروڊس: شروع ڪريو Oral Prednisone or Prednisolone 1.0 کان 1.5 mg/kg/day (60 کان 100 mg روزانو هڪ ڀيرو)، يا ڌماڪي واري پوسٽ آپريٽو يا ملٽي السر جي بيماري لاءِ، انتظام ڪريو پلس IV ميٿيلپريڊنيسولون لاءِ روزاني m0001،000014 5 ڏينهن). هڪ دفعو سرحد جي ترقي بند ٿي وڃي ٿي ۽ هيٺيون اوور هينگ (1 کان 3 هفتي اندر) ٿلهو ٿي وڃي ٿو، 3 کان 6 مهينن تائين سست ٿي وڃي ٿو.
• Oral Cyclosporine (Calcineurin Inhibitor): شروع ڪريو Oral Modified Cyclosporine (Neoral) 4 کان 5 mg/kg/day تي ورهايل ٻه ڀيرا روزانو. تاريخي نشان ۾ STOP GAP بي ترتيب ٿيل ڪنٽرول ٿيل آزمائشي، زباني سائڪولوسپورين (4 mg/kg/day) ۽ oral prednisolone (0.75 mg/kg/day) 6 هفتن ۾ هڪجهڙي شفا جي رفتار ڏيکاري ٿي ۽ 6 مهينن ۾ هڪجهڙي بندش جي شرح ڏيکاري ٿي (47٪)، وڌيڪ سنجيده انفڪشن کڻڻ واري ريورسائيڪلوسپورن سان گڏ. dysfunction ۽ hypertension. هر 1 کان 2 هفتا بلڊ پريشر، creatinine، پوٽاشيم ۽ ميگنيشيم جي نگراني ڪريو.

2. ھدف ٿيل بايولوجيڪ ۽ اسٽريروڊ اسپرنگ تھراپي¶

• TNF-Alpha Inhibitors (Infliximab and Adalimumab): IV Infliximab (5 mg/kg هفتا 0، 2، 6، پوءِ هر 6 کان 8 هفتا) گولڊ-معياري حياتياتي ايجنٽ آهي PG لاءِ، خاص طور تي ** ڪرون ڊيزيز، السرٽيوٽو بي بي (Perentalistomab) لاءِ ۽ هيپاٽائيٽس بي پهريون). Subcutaneous Adalimumab (160 mg هفتو 0، 80 mg هفتو 2، پوءِ 40 کان 80 mg هفتيوار) هڪ مؤثر ذيلي هيٺان اختيار آهي.
• IVIG، اسٽيرائڊ-اسپارنگ ايجنٽ، ۽ سائٽوڪائن بلاڪرز: ڏيو IVIG (2 g/kg 3 کان 5 ڏينهن کان وڌيڪ) جڏهن فعال خرابي يا سيپسس اسٽيرائڊس کي رد ڪري ٿو. Oral Dapsone (G6PD اسڪريننگ کان پوءِ 50 کان 200 mg/ڏينهن)، Mycophenolate Mofetil، Azathioprine، يا Colchicine سان اسٽيرائڊس يا حياتيات کي گڏ ڪريو. ريفرڪٽري ڪيسن يا PAPA/PASH syndromes لاءِ، IL-1 مخالفن (Anakinra، Canakinumab)، IL-23 inhibitors (Ustekinumab)، ۽ JAK inhibitors (Upadacitinib) تيز معافي حاصل ڪن ٿا.

3. Pyoderma Gangrenosum ۾ سرجيڪل چمڙي جي گرافنگ جي اجازت ڪڏهن آهي؟¶

• ** فعال سوزش جي دوران:** ڪڏهن به نه. ڪنهن به قسم جي جراحتي چيرا، تيز خرابي، يا چمڙي جي گرافٽ هارويسٽ (جيڪا ران ڊونر سائيٽ تي هڪ نئون PG السر پيدا ڪري ٿي) سختي سان منع ٿيل آهي.
• مکمل اميونوسپريشن تحت خاموش شفا جي مرحلي دوران: هڪ ڀيرو اسٽيرائڊس، سائڪلوسپورين، يا انفلڪسيماب نيوٽروفيلڪ سرحد کي مڪمل طور تي ختم ڪري ڇڏيا آهن ۽ درد ختم ٿي ويو آهي، ** نرم سلوو هٽائڻ، منفي پريشر زخم جو علاج (NPWT)، يا بايو انجنيئر استعمال ڪري سگھن ٿا **.

علائقائي ايمرجنسي نمبر ۽ ايجنسي پروٽوڪول¶

• United States and Canada: Dial 911 for rapidly expanding necrotic skin ulcers accompanied by high fever, rigors, or intractable pain. Clinicians follow American Academy of Dermatology (AAD) and Delphi International Consensus diagnostic and pathergy-prevention protocols.
• United Kingdom: ڊائل ڪريو 999 يا NHS ايمرجنسي ڊپارٽمينٽ ڏانھن وڃو. برٽش ايسوسيئشن آف ڊرماتولوجسٽس (BAD) ۽ UK Dermatology Clinical Trials Network (UK DCTN STOP GAP Trial) جي ھدايتن تحت، اسپتال جون ڊرماتولوجي ٽيمون شروع ڪن ٿيون Oral prednisolone (\(0.75\text{ mg/kg/day}\)) يا cyclosporine ($4/text) لاءِ سخت جراحي کي ختم ڪرڻ تي پابندي.
• European Union: Dial 112 across all EU member states. Follow European Academy of Dermatology and Venereology (EADV) and German Dermatologic Society (DDG) PARACELSUS Score guidelines.
• Australia, New Zealand, and Asia-Pacific: Dial 000 in Australia, 111 in New Zealand (Australasian College of Dermatologists [ACD]), 119 in Japan and South Korea (Japanese Dermatological Association [JDA] Pyoderma Gangrenosum Guidelines, where Adalimumab carries formal regulatory approval), 995 in Singapore, or 112 / 108 in India.

اڪثر پڇيا ويا سوال¶

Why does surgical debridement make a Pyoderma Gangrenosum ulcer catastrophically worse?¶

Unlike necrotizing fasciitis (which is caused by flesh-eating bacteria that must be cut away in the operating room), Pyoderma Gangrenosum (PG) is a sterile autoimmune and autoinflammatory condition in which the patient's own white blood cells (neutrophils) mistakenly attack the skin whenever it is injured. This exaggerated reaction to trauma is called cutaneous pathergy. When a surgeon mistakes a purulent PG ulcer for a bacterial infection and cuts away the purple skin border with a scalpel, the damaged skin cells release alarm signals (interleukin-1 beta and TNF-alpha) that summon millions of fresh neutrophils to the newly cut edge. Within 24 to 48 hours, those neutrophils digest the healthy collagen along the surgical margin, causing the ulcer to double or triple in size.

How can doctors tell Postoperative Pyoderma Gangrenosum apart from a bacterial surgical wound infection after breast or abdominal surgery?¶

Four clinical clues separate Postoperative Pyoderma Gangrenosum (PPG) from a bacterial wound infection: (1) Timing: PPG almost always starts 4 to 14 days after surgery as tiny sterile pustules along the incision line that suddenly merge and rip the wound open, whereas virulent Group A Strep necrotizing infections strike within 24 to 72 hours; (2) Border appearance: PPG creates a boggy, gunmetal-purple, overhanging ("undermined") skin edge; (3) Nipple sparing in breast surgery: in breast reduction or reconstruction PPG, the skin of the breast melts away while the nipple-areolar complex is uniquely spared; and (4) Antibiotic failure: PPG worsens despite broad-spectrum intravenous antibiotics and surgical debridements, yet stops expanding within 48 hours of starting high-dose corticosteroids.

Why is Pyoderma Gangrenosum called "Pyoderma" if there is no bacterial infection?¶

When dermatologists Brunsting, Goeckerman, and O'Leary first named the condition in 1930, they mistakenly believed it was caused by a runaway streptococcal or staphylococcal infection ("pyoderma" means pus in the skin) that led to tissue death ("gangrenosum"). Modern medicine later proved that the thick yellow pus covering the base of a fresh PG ulcer contains zero bacteria; it is actually a sterile soup made of millions of hyperactive white blood cells (neutrophils) that have flooded the dermis due to an overactive innate immune system. Although the name is a historical misnomer, it has remained in medical textbooks for nearly a century.

What underlying medical conditions are most commonly linked to Pyoderma Gangrenosum?¶

Between 50 and 70 percent of patients diagnosed with Pyoderma Gangrenosum have an underlying systemic illness. The four most common associations are: (1) Inflammatory Bowel Disease (Ulcerative Colitis and Crohn Disease, seen in 20% to 30% of cases); (2) Inflammatory Arthritis (Rheumatoid Arthritis and ankylosing spondylitis); (3) Hematologic cancers and blood disorders (specifically Acute Myeloid Leukemia [AML], Myelodysplastic Syndrome [MDS], and IgA Monoclonal Gammopathy, which are especially linked to the bullous variant of PG on the hands and face); and (4) Genetic autoinflammatory syndromes like PAPA and PASH syndrome.

Which works better for Pyoderma Gangrenosum: Prednisone or Cyclosporine?¶

According to the landmark UK STOP GAP randomized controlled trial, oral Prednisolone (0.75 mg/kg/day) and oral Cyclosporine (4 mg/kg/day) are equally effective: both stop ulcer progression at the same speed and achieve virtually identical complete healing rates (nearly 50% healed by 6 months). Doctors choose between them based on the patient's other health conditions: Prednisone (or IV Methylprednisolone) is favored in patients with kidney disease or high blood pressure, while Cyclosporine is favored in patients with diabetes, obesity, osteoporosis, or a history of steroid-induced psychiatric side effects. When PG is linked to Crohn disease or Ulcerative Colitis, intravenous Infliximab (5 mg/kg) is the gold-standard biologic treatment.

ذريعن ۽ سرڪاري هدايتون¶

• JAMA Dermatology Delphi International Consensus (Maverakis E, Ma C, Shinkai K, et al., 2018): Diagnostic Criteria of Ulcerative Pyoderma Gangrenosum: A Delphi Consensus of International Experts.
• BMJ (STOP GAP Randomized Controlled Trial, Ormerod AD, Thomas KS, Craig FE, et al., UK Dermatology Clinical Trials Network): Comparison of the Two Most Commonly Used Treatments for Pyoderma Gangrenosum: Results of the STOP GAP Randomised Controlled Trial (Prednisolone vs. Ciclosporin).
• JAMA Dermatology (Jockenhovel F, et al.): The PARACELSUS Score: A Novel Diagnostic Tool for Pyoderma Gangrenosum.
• British Association of Dermatologists (BAD) and American Academy of Dermatology (AAD): Clinical Guidelines on Neutrophilic Dermatoses, Postoperative Pyoderma Gangrenosum Recognition, and Pathergy Prevention.
• Gut (Brooklyn TN, Dunnill MG, Shetty A, et al.): Infliximab for the Treatment of Pyoderma Gangrenosum: A Randomised, Double-Blind, Placebo-Controlled Trial.

لاڳاپيل ھدايتون¶

• Calciphylaxis (calcific uremic arteriolopathy): violaceous plaques, black eschars, and sodium thiosulfate
• Erysipelas vs necrotizing fasciitis vs stasis dermatitis: pain out of proportion, bullae, and LRINEC score triage
• Black widow latrodectism muscle rigidity vs brown recluse loxoscelism necrotic ulcer triage
• Necrotizing fasciitis (flesh-eating infection) and cellulitis red flags
• ملڪ طرفان هنگامي نمبر